Eli Lilly Wins in LPG-1 Market Over Novo Nordisk, Earnings Show
The Eli Lilly and Novo Nordisk logos. Mike Blake | Little Tom | Reuters It's the story of two drugmakers…
Novo Nordisk A/S
Pfizer's monthly anti-obesity shot shows promise in trial
Smith Collection | Stock Photos | fake images Pfizer on Tuesday said its experimental anti-obesity drug, which it acquired through…
Eli Lilly CEO David Ricks Discusses Medicare Coverage of Obesity Pills
Eli Lilly Chief Executive Dave Ricks said Friday that upcoming Medicare coverage of obesity drugs could be a major catalyst…
Eli Lilly plans $3.5 billion plant in Pennsylvania for obesity drugs
Eli Lilly Chairman and CEO Dave Ricks speaks during a news conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
Structure Therapeutics CEO talks obesity pill and more
Ray Stevens, CEO of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in San Francisco,…
Novo Nordisk and Pfizer executives weigh in
US President Donald Trump arrives to make an announcement in the Roosevelt Room of the White House in Washington, DC,…
Novo Nordisk shares rise after launch of anti-obesity pill Wegovy
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, on January 15, 2026. George Frey…
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
What to expect from the pharmaceutical industry at the JPM conference
Heidi Overton, Novo Nordisk CEO Maziar “Mike” Doustdar, Eli Lilly CEO David Ricks and Commerce Secretary Howard Lutnick listen as…
Abivax Stock Rises to Become Top Biotech Acquisition Target
Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…